| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.03.23 | Extraordinary General Meeting in Nelly Group on 14 March 2023 | 247 | GlobeNewswire (Europe) | Nelly Group AB (publ) ("Nelly") today held an Extraordinary General Meeting. The Extraordinary General Meeting resolved in accordance with all proposals of the Board.
On 3 February 2023, the Board of... ► Artikel lesen | |
| 14.03.23 | Amundi: Change to Amundi's corporate governance | 946 | GlobeNewswire (Europe) | Press release Change to Amundi's corporate governance London, 14 March 2023 - In 2021, Yves Perrier accepted the chairmanship of Amundi's Board of Directors in order to support the company during... ► Artikel lesen | |
| 14.03.23 | Rafael Holdings, Inc.: Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results | 361 | GlobeNewswire (Europe) | NEWARK, N.J., March 14, 2023 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its second quarter fiscal 2023 financial results for the three months and six months ended January... ► Artikel lesen | |
| 14.03.23 | Pardes Biosciences, Inc: Pardes Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update | 229 | GlobeNewswire (Europe) | Data from ongoing Phase 2 trial evaluating pomotrelvir (formerly known as PBI-0451) for the treatment of COVID-19 expected in the coming weeks Cash to fund operations for the next twelve months CARLSBAD... ► Artikel lesen | |
| 14.03.23 | Arbutus Biopharma Corporation: Arbutus Presents AB-343 Data at the 36th International Conference on Antiviral Research | 528 | GlobeNewswire (Europe) | Antiviral potency, selectivity and favorable PK support further development of AB-343 as potential ritonavir-free oral treatment for COVID-19 and other human coronaviruses WARMINSTER, Pa., March 14... ► Artikel lesen | |
| 14.03.23 | Yield10 Bioscience, Inc.: Yield10 Bioscience Announces Fourth Quarter and Full Year 2022 Financial Results | 592 | GlobeNewswire (Europe) | -Executing strategy to build supply chain alliances for the production of low-carbonintensity Camelina feedstock oil for the biofuels market-Advancing development of herbicide tolerant Camelina varieties-Accelerating... ► Artikel lesen | |
| 14.03.23 | Snap One Reports Fiscal Fourth Quarter and Full Year 2022 Results | 317 | GlobeNewswire (Europe) | Full Year 2022 Net Sales of $1.124 Billion Notable Achievements Across Product Suite and Growth Verticals Build on Best-In-Class Integrator Partner Experience Company Introduces Financial Outlook... ► Artikel lesen | |
| 14.03.23 | Lulu's Fashion Lounge Holdings, Inc.: Lulus Reports Fourth Quarter 2022 Results and Record Fiscal Year Net Revenue | 548 | GlobeNewswire (Europe) | Record-Breaking Full Year 2022 Net Revenue of $440 million, up 17% from 2021 Full Year Net Income of $3.7 million, up 82% from 2021 Grew Active Customers, up 17% from 2021 CHICO, Calif., March 14, 2023... ► Artikel lesen | |
| 14.03.23 | INNOVATE Corp. Announces Fourth Quarter and Full Year 2022 Results | 247 | GlobeNewswire (Europe) | - Infrastructure: DBM Global finishes year strong; achieves 37% revenue growth for 2022 -- Life Sciences: MediBeacon completed enrollment of both U.S. and China Pivotal Studies -- Spectrum: Broadcasting... ► Artikel lesen | |
| 14.03.23 | Decibel Therapeutics, Inc.: Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update | 771 | GlobeNewswire (Europe) | - Received clearance from US FDA for IND and from UK MHRA for CTA to initiate CHORD, a global Phase 1/2 dose escalation clinical trial of DB-OTO in pediatric patients - - Plan to initiate the CHORD... ► Artikel lesen | |
| 14.03.23 | Westrock Coffee Reports Fourth Quarter and Full Year 2022 Results and Provides 2023 Outlook | 460 | GlobeNewswire (Europe) | Net Sales for the Fourth Quarter and Full Year 2022 Increase by 20% and 24%, Respectively Net Loss of $55.5 Million and Adjusted EBITDA of $60.1 Million for the Full Year 2022, Representing Adjusted... ► Artikel lesen | |
| 14.03.23 | Design Therapeutics, Inc.: Design Therapeutics Highlights Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results | 373 | GlobeNewswire (Europe) | Phase 1 Multiple-Ascending Dose Trial of DT-216 for Friedreich Ataxia Ongoing with Data Expected Mid-Year Continued Progress Across Pipeline of GeneTAC Small Molecules with Three Programs Expected... ► Artikel lesen | |
| 14.03.23 | StoneCo Ltd.: StoneCo Reports Fourth Quarter and Fiscal Year 2022 Results | 350 | GlobeNewswire (Europe) | Key 4Q22 metrics exceeded guidance on strength of 2022 execution; Revenue of R$2.7 billion, + 44% y/y (vs R$2.6+ billion guidance); Adj. EBT of R$316 million, +50% q/q (vs R$250+ million guidance);... ► Artikel lesen | |
| 14.03.23 | BRT Apartments Corp. Reports Fourth Quarter and Full Year 2022 Results | 638 | GlobeNewswire (Europe) | - Issues Full Year 2023 Guidance - GREAT NECK, N.Y., March 14, 2023 (GLOBE NEWSWIRE) -- BRT APARTMENTS CORP. (NYSE:BRT), a real estate investment trust that owns, operates, and, to a lesser extent,... ► Artikel lesen | |
| 14.03.23 | IO Biotech Announces 2022 Fourth-Quarter and Year-End Results | 173 | GlobeNewswire (Europe) | Enrollment in the company's Phase 3 pivotal trial (IOB-013/KN-D18) in advanced melanoma accelerated in the second half of 2022; the company expects to enroll 75% of patients by mid-2023 and fully enroll... ► Artikel lesen | |
| 14.03.23 | PFSweb, Inc.: PFSweb Reports Strong Fourth Quarter and Full Year 2022 Results | 1.375 | GlobeNewswire (Europe) | Demonstrates Strong 2022 Results and Continued Momentum Into 2023, Backed by Record Annual Sales Bookings and Order Fulfillment Performance Full Year 2023 Guidance of Annual Service Fee Revenue Growth... ► Artikel lesen | |
| 14.03.23 | Sigilon Therapeutics, Inc.: Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights | 552 | GlobeNewswire (Europe) | Advancing IND-enabling activities for lead program in diabetes, SIG-002, with plans to conduct non-human primate studies in second half of 2023 SIG-002 demonstrated efficacy and durability in in vivo... ► Artikel lesen | |
| 14.03.23 | GeneDx Holdings Corp.: GeneDx Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights | 334 | GlobeNewswire (Europe) | Financial results are in line with previously announced preliminary 2022 results; Reiterating 2023 guidance, including total revenue of $205-220 million Completed financing in January 2023 with... ► Artikel lesen | |
| 14.03.23 | Affimed N.V.: Affimed Announces Presentations of Clinical Data from AFM13 Phase 2 REDIRECT and Pre-clinical Data Demonstrating CD16A Shedding Facilitates Repetitive Targeting of Tumor Cells by AFM13-armed NK Cells at the Annual Meeting of the American Ass | 254 | GlobeNewswire (Europe) | An oral presentation on the safety and efficacy from the AFM13 phase 2 monotherapy clinical study ("REDIRECT") in patients with CD30-positive relapsed or refractory (R/R) peripheral T-cell lymphoma... ► Artikel lesen | |
| 14.03.23 | Travere Therapeutics, Inc.: Travere Therapeutics to Present Abstracts at the Society for Inherited Metabolic Disorders 44th Annual Meeting and the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting 2023 | 128 | GlobeNewswire (Europe) | SAN DIEGO, March 14, 2023 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the Company will present a quantitative systems pharmacology (QSP) model for predicting the... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 3.296 |
| EVOTEC | 2.636 |
| TUI | 2.075 |
| NEL | 1.327 |
| BAYER | 1.147 |
| PLUG POWER | 1.143 |
| NVIDIA | 1.137 |
| RHEINMETALL | 1.061 |
| AMC ENTERTAINMENT | 1.034 |
| DEUTSCHE BANK | 960 |
| SIEMENS ENERGY | 936 |
| RENK GROUP | 874 |
| REDCARE PHARMACY | 727 |
| COMMERZBANK | 726 |
| HEIDELBERGER DRUCK | 701 |
| ALIBABA | 676 |
| VOLKSWAGEN | 671 |
| E.ON | 619 |
| BARRICK GOLD | 612 |
| BYD | 592 |
| RWE | 585 |
| SIEMENS | 565 |
| TESLA | 562 |
| DEUTSCHE LUFTHANSA | 560 |
| AIXTRON SE | 554 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
